Christopher Bunka - 29 Aug 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
29 Aug 2022
Net transactions value
$0
Form type
4
Filing time
29 Aug 2022, 17:18:43 UTC
Previous filing
02 Sep 2021
Next filing
18 Oct 2022

Quoteable Key Fact

"Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 29 Aug 2022."

Quick Takeaways

  • This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 5 derivative rows are listed below.
  • Filing timestamp: 29 Aug 2022, 17:18.

What Changed

  • Previous filing in this sequence was filed on 02 Sep 2021.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 215,912 29 Aug 2022 Private Holding Company
holding LEXX common shares 273,543 29 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +30,000 +42% $0.000000 101,001 29 Aug 2022 Common Shares 30,000 $2.91 Direct
holding LEXX Warrants 6,667 29 Aug 2022 Common Shares 6,667 $10.50 Private Holding Company
holding LEXX Stock Options 32,667 29 Aug 2022 Common Shares 26,000 $5.83 Direct
holding LEXX Stock Options 56,001 29 Aug 2022 Common Shares 23,334 $7.08 Direct
holding LEXX Stock Options 71,001 29 Aug 2022 Common Shares 15,000 $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .